Xycota Advances At-Home Brain Repair Research Alongside Free Support Platform for Veterans

New York, Wednesday, 11 November 2026.
Xycota Biosciences launched a privacy-first support hub while advancing clinical trials for an at-home, low-dose psilocybin treatment designed to trigger neural repair without causing hallucinations or requiring lengthy clinic visits.